Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/01/2023 | AVADEL PHARMACEUTICALS PLC | AVDL | Grant | Stock Option (Right to Buy) | 33k | $14.10 | $465.3k | | 08/01/2023 |
05/18/2023 | AVADEL PHARMACEUTICALS PLC | AVDL | Purchase | | 13k | $13.93 | $181.1k | | 05/18/2023 |
11/22/2022 | AVADEL PHARMACEUTICALS PLC | AVDL | Purchase | | 20k | $7.80 | $156k | | 11/22/2022 |
11/14/2022 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Stock option (right to buy) | 142.7k | $0.73 | $103.7k | | 11/14/2022 |
09/09/2022 | NeuBase Therapeutics, Inc. | OHRP | Grant | Stock option (right to buy) | 37.6k | $0.60 | $22.6k | | 09/09/2022 |
08/03/2022 | AVADEL PHARMACEUTICALS PLC | AVDL | Grant | Stock Option (Right to Buy) | 42k | $4.79 | $201.2k | | 08/03/2022 |
06/01/2022 | AVADEL PHARMACEUTICALS PLC | AVDL | Purchase | | 20k | $2.27 | $45.5k | | 05/31/2022 |
05/31/2022 | AVADEL PHARMACEUTICALS PLC | AVDL | Purchase | | 15k | $2.16 | $32.4k | | 05/31/2022 |
05/27/2022 | AVADEL PHARMACEUTICALS PLC | AVDL | Purchase | | 15k | $2.45 | $36.7k | | 05/27/2022 |
01/01/2022 | NeuBase Therapeutics, Inc. | OHRP | Grant | Stock option (right to buy) | 165.8k | $2.95 | $489.1k | | 01/01/2022 |
11/01/2021 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Stock option (right to buy) | 90.9k | $1.12 | $101.8k | | 11/01/2021 |
08/03/2021 | AVADEL PHARMACEUTICALS PLC | AVDL | Grant | Stock Option (Right to Buy) | 42k | $8.07 | $338.9k | | 08/03/2021 |
06/19/2021 | Matinas BioPharma Holdings, Inc. | MTNB | Conversion | Series B Preferred Stock | 12 | $0.50 | $6 | | 06/19/2021 |
06/19/2021 | Matinas BioPharma Holdings, Inc. | MTNB | Conversion | Common Stock, par value $0.0001 per share | 24k | $0.00 | $0 | | 06/19/2021 |
06/19/2021 | Matinas BioPharma Holdings, Inc. | MTNB | Other (acquisition) | Common Stock, par value $0.0001 per share | 4.8k | $0.00 | $0 | | 06/19/2021 |
11/02/2020 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Stock option (right to buy) | 122.6k | $0.82 | $100.5k | | 11/02/2020 |
09/17/2020 | AVADEL PHARMACEUTICALS PLC | AVDL | Purchase | | 17k | $5.79 | $98.4k | | 09/17/2020 |
08/13/2020 | AVADEL PHARMACEUTICALS PLC | AVDL | Purchase | | 3.8k | $7.80 | $29.6k | | 08/13/2020 |
08/13/2020 | AVADEL PHARMACEUTICALS PLC | AVDL | Purchase | | 1.2k | $7.74 | $9.3k | | 08/13/2020 |
08/12/2020 | AVADEL PHARMACEUTICALS PLC | AVDL | Purchase | | 15k | $7.76 | $116.4k | | 08/12/2020 |
08/07/2020 | AVADEL PHARMACEUTICALS PLC | AVDL | Grant | Stock Option (Right to Buy) | 42k | $8.48 | $356.2k | | 08/07/2020 |
06/23/2020 | Matinas BioPharma Holdings, Inc. | MTNB | Other (acquisition) | Common Stock, par value $0.0001 per share | 3.6k | $0.00 | $0 | | 06/23/2020 |
06/19/2020 | PROGENICS PHARMACEUTICALS INC | PGNX | Disposition | Stock Option (Right to Buy) | 40k | $5.01 | $200.4k | | 06/19/2020 |
06/19/2020 | PROGENICS PHARMACEUTICALS INC | PGNX | Disposition | Stock Option (Right to Buy) | 16.4k | $5.01 | $82.1k | | 06/19/2020 |
12/13/2019 | PROGENICS PHARMACEUTICALS INC | PGNX | Grant | Non-Qualified Stock Option (Right to Buy) | 16.4k | $5.01 | $82.1k | | 12/13/2019 |
12/13/2019 | PROGENICS PHARMACEUTICALS INC | PGNX | Grant | Non-Qualified Stock Option (Right to Buy) | 40k | $5.01 | $200.4k | | 12/13/2019 |
12/04/2019 | AVADEL PHARMACEUTICALS PLC | AVDL | Purchase | | 10k | $5.97 | $59.7k | | 12/04/2019 |
11/15/2019 | AVADEL PHARMACEUTICALS PLC | AVDL | Purchase | | 10k | $4.98 | $49.8k | | 11/15/2019 |
11/01/2019 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Stock option (right to buy) | 107.4k | $0.91 | $98k | | 11/01/2019 |
08/20/2019 | Matinas BioPharma Holdings, Inc. | MTNB | Purchase | Common Stock, par value $0.0001 per share | 20k | $0.66 | $13.2k | | 08/20/2019 |
08/19/2019 | Matinas BioPharma Holdings, Inc. | MTNB | Purchase | Common Stock, par value $0.0001 per share | 20k | $0.68 | $13.6k | | 08/19/2019 |
08/07/2019 | AVADEL PHARMACEUTICALS PLC | AVDL | Grant | Stock Option (right to buy) | 60k | $2.03 | $121.8k | | 08/07/2019 |
06/21/2019 | Matinas BioPharma Holdings, Inc. | MTNB | Other (acquisition) | Common Stock, par value $0.0001 per share | 2.4k | $0.00 | $0 | | 11/01/2019 |
05/22/2019 | AVADEL PHARMACEUTICALS PLC | AVDL | Grant | Stock Option (right to buy) | 8.1k | $1.49 | $12k | | 05/22/2019 |
01/31/2019 | AVADEL PHARMACEUTICALS PLC | AVDL | Grant | | 27.9k | $0.00 | $0 | | 01/31/2019 |
|